- Home
- ZNTL vs NMT Comparison
ZNTL vs NMT Comparison
Compare ZNTL & NMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- NMT
- Stock Information
- Founded
- ZNTL 2014
- NMT 1993
- Country
- ZNTL United States
- NMT United States
- Employees
- ZNTL N/A
- NMT N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- NMT Finance/Investors Services
- Sector
- ZNTL Health Care
- NMT Finance
- Exchange
- ZNTL Nasdaq
- NMT Nasdaq
- Market Cap
- ZNTL 137.9M
- NMT 110.6M
- IPO Year
- ZNTL 2020
- NMT N/A
- Fundamental
- Price
- ZNTL $1.63
- NMT $11.80
- Analyst Decision
- ZNTL Buy
- NMT
- Analyst Count
- ZNTL 8
- NMT 0
- Target Price
- ZNTL $8.53
- NMT N/A
- AVG Volume (30 Days)
- ZNTL 852.5K
- NMT 19.1K
- Earning Date
- ZNTL 03-26-2025
- NMT 01-01-0001
- Dividend Yield
- ZNTL N/A
- NMT 3.21%
- EPS Growth
- ZNTL N/A
- NMT N/A
- EPS
- ZNTL N/A
- NMT N/A
- Revenue
- ZNTL $67,425,000.00
- NMT N/A
- Revenue This Year
- ZNTL N/A
- NMT N/A
- Revenue Next Year
- ZNTL N/A
- NMT N/A
- P/E Ratio
- ZNTL N/A
- NMT N/A
- Revenue Growth
- ZNTL N/A
- NMT N/A
- 52 Week Low
- ZNTL $1.58
- NMT $9.05
- 52 Week High
- ZNTL $16.27
- NMT $10.93
- Technical
- Relative Strength Index (RSI)
- ZNTL 36.50
- NMT 53.11
- Support Level
- ZNTL $1.78
- NMT $11.72
- Resistance Level
- ZNTL $2.02
- NMT $11.78
- Average True Range (ATR)
- ZNTL 0.15
- NMT 0.09
- MACD
- ZNTL -0.00
- NMT -0.01
- Stochastic Oscillator
- ZNTL 3.53
- NMT 43.33
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.
About NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes by investing in a portfolio of municipal obligations issued by state and local government authorities within a single state or certain U.S. territories.